286 Cardinal Medeiros AvenueCambridge, MA 02141
President & CEO
Seventh Sense Biosystems, Inc.
Founded in 2008, within Flagship VentureLabs™, Seventh Sense is developing an array of products based on the company's proprietary Touch Activated Phlebotomy (TAP™) painless blood collection platform, with an initial focus on enabling important diagnostic testing at the point of care by reducing the discomfort, anxiety and hassle of blood sample collection.
Harry Wilcox is on the Board of Directors.